CANCER RESEARCH INSTITUTE INC
Programs
Clinical Accelerator Grants Program
CLINICAL ACCELERATOR GRANTS PROGRAM - SEE SCHEDULE OTHE CRI ANNA-MARIA KELLEN CLINICAL ACCELERATOR : IS AN ACTIVELY MANAGED VENTURE PHILANTHROPY PROGRAM DESIGNED TO SPEED THE DEVELOPMENT OF PROMISING NEW CANCER IMMUNOTHERAPY COMBINATIONS. THIS MODEL FACILITATES RESEARCH COLLABORATION ACROSS LEADING BIOPHARMA COMPANIES AND THE CRI NETWORK OF IMMUNO-ONCOLOGY EXPERTS. THE PROGRAM INCLUDES PLATFORM CLINICAL TRIALS THAT ARE COLLABORATIVE, INTEGRATIVE, SCIENCE/DATA-DRIVEN, AND HYPOTHESIS-ANSWERING CLINICAL STUDIES. CRI PLANS, IMPLEMENTS, INVESTS IN, AND MANAGES EACH CLINICAL ACCELERATOR CLINICAL TRIAL AND WORKS CLOSELY WITH ACADEMIC RESEARCHER AND INDUSTRY PARTNERS ON SUCH STUDIES. EACH CLINICAL TRIAL AND PHILANTHROPIC INVESTMENT BRINGS A POTENTIAL NEW CANCER TREATMENT CLOSER TO PATIENTS, EMPOWERS ACADEMIC RESEARCHERS TO WORK MORE CLOSELY WITH INDUSTRY, AND CREATES A POTENTIAL RETURN ON INVESTMENT TO BE USED TO SUPPORT FURTURE CLINICAL EFFORTS.GeographiesNot indicatedDatesJul 1, 2022 – Jun 30, 2023Source990No causes providedNo populations provided–$6.8MPostdoctoral Fellowship Program
FELLOWSHIP PROGRAM - SEE SCHEDULE OTHE CRI POSTDOCTORAL FELLOWSHIP PROGRAM INCLUDES THREE TRACKS OF FELLOWSHIPS PROVIDING CAREER DEVELOPMENT, TRAINING, AND DIVERSITY BUILDING IN IMMUNOLOGY AND IMMUNO-INFOMATICS. THE CRI IRVINGTON POSTDOCTORAL FELLOWSHIP, CRI IRVINGTON POSTDOCTORAL FELLOWSHIP TO PROMOTE RACIAL DIVERSITY, AND THE CRI IMMUNO-INFORMATICS FELLOWSHIP EACH SUPPORT YOUNG IMMUNOLOGISTS AND CANCER IMMUNOLOGISTS AT TOP UNIVERSITIES AND RESEARCH CENTERS AROUND THE WORLD. FELLOWS RECEIVE UP TO $243,000 OVER THREE YEARS TO COVER THE COST OF STIPEND, INCLUDING AN INSTITUTIONAL ALLOWANCE TO HELP PAY FOR THE FELLOW'S RESEARCH SUPPLIES, TRAVEL TO SCIENTIFIC MEETINGS, HEALTH INSURANCE, AND/OR CHILDCARE. OF THE MORE THAN 1,550 CRI POSTDOCTORAL FELLOWS FUNDED TO DATE, MANY HAVE SINCE BECOME HEADS OF MAJOR MEDICAL RESEARCH INSTITUTES, ACADEMIC LEADERS IN PRESTIGIOUS UNIVERSITIES, AND ADMIRED MENTORS TO THE NEXT GENERATION OF IMMUNOLOGISTS AND TUMOR IMMUNOLOGISTS.GeographiesNot indicatedDatesJul 1, 2022 – Jun 30, 2023Source990No causes providedNo populations provided–$6.6MLloyd J. Old STAR Program
STAR PROGRAM - SEE SCHEDULE OTHE LLOYD J. OLD STAR PROGRAM, LAUNCHED IN 2019, PROVIDES GRANTS OF $1.25 MILLION OVER 5 YEARS TO MID-CAREER SCIENTISTS. THIS LONGTERM FUNDING IS NOT TIED TO A SPECIFIC RESEARCH PROJECT, BUT RATHER AIMS TO PROVIDE A DEGREE OF FLEXIBILITY AND FREEDOM FOR INVESTIGATORS TO EXPLORE OUTSIDE-THE-BOX AND DISRUPTIVE AVENUES OF RESEARCH. CANDIDATES SELECTED FOR THIS AWARD ARE EXPECTED TO BE FUTURE "STARS" IN THE FIELD OF CANCER IMMUNOLOGY: SCIENTISTS TAKING RISKS.GeographiesNot indicatedDatesJul 1, 2022 – Jun 30, 2023Source990No causes providedNo populations provided–$6.3M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)